RH · Rh

Track RH — free

$144.80 -3.77 (-2.54%) At close · Aug 27

Market Cap

$2.81B

18.90M

Up next

Next earnings call

Sep 10, 2026 Est · unconfirmed · in 2 wks

FQ3-27 quarter ends

~Oct 31, 2026 Est

Latest filing: 10-Q

filed Jun 11, 2026

Equibles Rating

blended score · not investment advice

Overall

Sell

SellHoldBuy

Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very High

Market backdrop VIX 14.5 · calm Equity put/call 0.39

Technical

price trend

Sell

50 / 200-day cross No cross

Price vs 200-day avg −11%

below

Price vs 50-day avg −14%

below

RSI (14) 35

neutral

MACD trend Negative

52-week position 23%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Very Weak

1-month return −13%

trailing

6-month return +2%

trailing

YTD return −19%

this year

Relative strength −13%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $169 › 200d $163 — 50d above 200d

Institutional flow Distributing

-1% holders QoQ · +75 funds added

Insider flow Distributing

Net -$20.0M over 90 days · 67% sells

Short interest Falling

26.29% of float · ▼ -4.0% MoM · 7.4 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr low

378 holders — near 3-yr low, contrarian setup

Squeeze score 74

high risk · 0–100

Fundamentals

Excellent

Revenue growth +25%

Y/Y

Gross margin 127%

contracting

EPS growth +74%

Y/Y

Free cash flow $252.4M

Valuation P/E 28.7

in line

Buyback $201.0M

remaining

Balance sheet $38.9M

net cash

Quant / Vol

risk profile

Very High

Volatility 61%

annualized · 1-yr

Max drawdown −55%

past year

ATR 6.4%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Beat or met 3 of last 3

Latest guidance · from the 8-K filed Jun 11, 2026

Revenue Growth · Fiscal Year 2026 Initiated 4.5% – 8%

Adjusted EBITDA Margin · Fiscal Year 2026 Non-GAAP Initiated 14.2% – 16%

Prior guidance period ended · from the 8-K filed Jun 11, 2026

Revenue Growth · second quarter 2026 0.5% – 2.5%

Adjusted EBITDA Margin · second quarter 2026 11.5% – 13%

Guided vs delivered · last 3 settled

Revenue guidance the year

guided $3.06B – $3.08B

guided $3.06B – $3.08B $3.59B Beat +17.0%

Revenues third quarter of fiscal 2023

guided $740M – $760M

guided $740M – $760M $869.07M Beat +15.9%

Revenues fourth quarter of fiscal 2023

guided $760M – $800M

guided $760M – $800M $772.5M In line

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell

3 · 4 · 0

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−11% Bearish

Price vs 50-day avg

−14% Bearish

RSI (14)

35 Neutral

MACD trend

Negative Bearish

52-week position

23% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bearish · 2 of 6

Trend (MA cross) No cross

50d $169 › 200d $163 — 50d above 200d

Institutional flow Distributing

-1% holders QoQ · +75 funds added

Insider flow Distributing

Net -$20.0M over 90 days · 67% sells

Short interest Falling

26.29% of float · ▼ -4.0% MoM · 7.4 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr low

378 holders — near 3-yr low, contrarian setup

Price context

position in its 52-week range

Range low $113 Now $145 · 23% Range high $251

vs 200-day avg -11% vs 50-day avg -14%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
Adjusted diluted net income (loss) per share non-GAAP	-$1.97	Three months ended May 2, 2026	—
Adjusted EBITDA non-GAAP	$56.9M	first quarter 2026	—

Adjusted EBITDA Margin non-GAAP	7.1%	first quarter 2026	—
Adjusted operating income non-GAAP	$2.58M	Three Months Ended May 2, 2026	—

Adjusted operating margin non-GAAP	0.3%	Three months ended May 2, 2026	—

Adjusted selling, general and administrative expenses margin non-GAAP	41.1%	Three months ended May 2, 2026	—
EBITDA	$71.8M	first quarter 2026	—
EBITDA Margin	9%	first quarter 2026	—
Free Cash Flow	$13.3M	first quarter 2026	—
Ratio of total net debt to trailing twelve months adjusted EBITDA non-GAAP	4.3	As of May 2, 2026	—
Trailing twelve months Adjusted EBITDA non-GAAP	$546.98M	Trailing Twelve Months Ended May 2, 2026	—
Trailing twelve months EBITDA non-GAAP	$514.63M	Trailing Twelve Months Ended May 2, 2026	—
Adjusted gross margin non-GAAP	44.2%	Year Ended January 31, 2026	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Specialty Retail — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
RH Rh this stock	$2.81B	-19.2%	+24.5%	28.7	26.3%
CASY Caseys General Stores Inc	$28.86B	+38.1%	+10.2%	40.7	3.1%
WSM Williams Sonoma Inc	$27.96B	+33.5%	+1.2%	26.6	4.5%
ULTA Ulta Beauty, Inc.	$23.35B	-10.7%	+9.7%	20.4	4.7%
BBY Best Buy Co Inc	$18.43B	+24.8%	+0.4%	16.2	6.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

378

% held: 134.4%
Net QoQ: +1.3M sh
Top holder: FMR LLC

Held Float

View

Held by Funds

Fund positions

317

View

Short & Settlement

Short Interest Falling

Shares short

5.0M

Days to cover: 7.4d
Change: -204.9K sh

View

Short Volume

Short vol %

51%

As of: Aug 27, 2026

Short Total

View

Fails to Deliver

FTD shares

Value: $8.6K
As of: Jul 31, 2026

View

Off-Exchange

Off-exchange %

47.8%

Week of: Jul 20, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$20.0M

Buyers / Sellers: 1 / 2

Buyers Sellers

View

Congressional Trades Buy

Member

Maria Elvira Salazar

Amount: $15.0K–$50.0K
Traded: Mar 19, 2026

View

Financials

Revenue (FY)

$2.6B

Net income (FY): $124.8M
EPS diluted: $6.31

View

Buybacks

Authorized

$2.5B

Remaining: $201.0M

Spent Remaining

View

Filings

SEC Filings

Latest

8-K

Filed: Jul 23, 2026
This year: 9

View

Proposed Sales

Value

$411.8K

Shares: 2.4K
Filed: Jul 10, 2026

View

Earnings & Events

Earnings Calls

Last call

Jun 11, 2026

View

Performance

	5D	20D	120D	MTD	YTD
RH	-7.4%	-12.9%	+1.9%	-12.5%	-19.2%
SPY	+1.1%	+4.0%	+14.7%	+3.2%	+13.1%
vs SPY	-8.5%	-16.9%	-12.8%	-15.7%	-32.3%

Capital returns

Buyback program · as of May 2, 2026

Authorized

$2.45B

Spent (derived)

$2.25B

Remaining

$201.00M

Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1528849 CUSIP 74967X103 13F (30d) 308 filings 304 filers Visit website Investor relations

RH · Rh

Price & Indicators

Up next

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns